Cargando…

Inflammation and Wasting of Skeletal Muscles in Kras-p53-Mutant Mice with Intraepithelial Neoplasia and Pancreatic Cancer—When Does Cachexia Start?

Skeletal muscle wasting critically impairs the survival and quality of life in patients with pancreatic ductal adenocarcinoma (PDAC). To identify the local factors initiating muscle wasting, we studied inflammation, fiber cross-sectional area (CSA), composition, amino acid metabolism and capillariza...

Descripción completa

Detalles Bibliográficos
Autores principales: Hildebrandt, Wulf, Keck, Jan, Schmich, Simon, Bonaterra, Gabriel A., Wilhelm, Beate, Schwarzbach, Hans, Eva, Anna, Bertoune, Mirjam, Slater, Emily P., Fendrich, Volker, Kinscherf, Ralf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139525/
https://www.ncbi.nlm.nih.gov/pubmed/35626644
http://dx.doi.org/10.3390/cells11101607
_version_ 1784714879295291392
author Hildebrandt, Wulf
Keck, Jan
Schmich, Simon
Bonaterra, Gabriel A.
Wilhelm, Beate
Schwarzbach, Hans
Eva, Anna
Bertoune, Mirjam
Slater, Emily P.
Fendrich, Volker
Kinscherf, Ralf
author_facet Hildebrandt, Wulf
Keck, Jan
Schmich, Simon
Bonaterra, Gabriel A.
Wilhelm, Beate
Schwarzbach, Hans
Eva, Anna
Bertoune, Mirjam
Slater, Emily P.
Fendrich, Volker
Kinscherf, Ralf
author_sort Hildebrandt, Wulf
collection PubMed
description Skeletal muscle wasting critically impairs the survival and quality of life in patients with pancreatic ductal adenocarcinoma (PDAC). To identify the local factors initiating muscle wasting, we studied inflammation, fiber cross-sectional area (CSA), composition, amino acid metabolism and capillarization, as well as the integrity of neuromuscular junctions (NMJ, pre-/postsynaptic co-staining) and mitochondria (electron microscopy) in the hindlimb muscle of LSL-Kras(G12D/+); LSL-TrP53(R172H/+); Pdx1-Cre mice with intraepithelial-neoplasia (PanIN) 1-3 and PDAC, compared to wild-type mice (WT). Significant decreases in fiber CSA occurred with PDAC but not with PanIN 1-3, compared to WT: These were found in the gastrocnemius (type 2x: −20.0%) and soleus (type 2a: −21.0%, type 1: −14.2%) muscle with accentuation in the male soleus (type 2a: −24.8%, type 1: −17.4%) and female gastrocnemius muscle (−29.6%). Significantly higher densities of endomysial CD68+ and cyclooxygenase-2+ (COX2+) cells were detected in mice with PDAC, compared to WT mice. Surprisingly, CD68+ and COX2+ cell densities were also higher in mice with PanIN 1-3 in both muscles. Significant positive correlations existed between muscular and hepatic CD68+ or COX2+ cell densities. Moreover, in the gastrocnemius muscle, suppressor-of-cytokine-3 (SOCS3) expressions was upregulated >2.7-fold with PanIN 1A-3 and PDAC. The intracellular pools of proteinogenic amino acids and glutathione significantly increased with PanIN 1A-3 compared to WT. Capillarization, NMJ, and mitochondrial ultrastructure remained unchanged with PanIN or PDAC. In conclusion, the onset of fiber atrophy coincides with the manifestation of PDAC and high-grade local (and hepatic) inflammatory infiltration without compromised microcirculation, innervation or mitochondria. Surprisingly, muscular and hepatic inflammation, SOCS3 upregulation and (proteolytic) increases in free amino acids and glutathione were already detectable in mice with precancerous PanINs. Studies of initial local triggers and defense mechanisms regarding cachexia are warranted for targeted anti-inflammatory prevention.
format Online
Article
Text
id pubmed-9139525
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-91395252022-05-28 Inflammation and Wasting of Skeletal Muscles in Kras-p53-Mutant Mice with Intraepithelial Neoplasia and Pancreatic Cancer—When Does Cachexia Start? Hildebrandt, Wulf Keck, Jan Schmich, Simon Bonaterra, Gabriel A. Wilhelm, Beate Schwarzbach, Hans Eva, Anna Bertoune, Mirjam Slater, Emily P. Fendrich, Volker Kinscherf, Ralf Cells Article Skeletal muscle wasting critically impairs the survival and quality of life in patients with pancreatic ductal adenocarcinoma (PDAC). To identify the local factors initiating muscle wasting, we studied inflammation, fiber cross-sectional area (CSA), composition, amino acid metabolism and capillarization, as well as the integrity of neuromuscular junctions (NMJ, pre-/postsynaptic co-staining) and mitochondria (electron microscopy) in the hindlimb muscle of LSL-Kras(G12D/+); LSL-TrP53(R172H/+); Pdx1-Cre mice with intraepithelial-neoplasia (PanIN) 1-3 and PDAC, compared to wild-type mice (WT). Significant decreases in fiber CSA occurred with PDAC but not with PanIN 1-3, compared to WT: These were found in the gastrocnemius (type 2x: −20.0%) and soleus (type 2a: −21.0%, type 1: −14.2%) muscle with accentuation in the male soleus (type 2a: −24.8%, type 1: −17.4%) and female gastrocnemius muscle (−29.6%). Significantly higher densities of endomysial CD68+ and cyclooxygenase-2+ (COX2+) cells were detected in mice with PDAC, compared to WT mice. Surprisingly, CD68+ and COX2+ cell densities were also higher in mice with PanIN 1-3 in both muscles. Significant positive correlations existed between muscular and hepatic CD68+ or COX2+ cell densities. Moreover, in the gastrocnemius muscle, suppressor-of-cytokine-3 (SOCS3) expressions was upregulated >2.7-fold with PanIN 1A-3 and PDAC. The intracellular pools of proteinogenic amino acids and glutathione significantly increased with PanIN 1A-3 compared to WT. Capillarization, NMJ, and mitochondrial ultrastructure remained unchanged with PanIN or PDAC. In conclusion, the onset of fiber atrophy coincides with the manifestation of PDAC and high-grade local (and hepatic) inflammatory infiltration without compromised microcirculation, innervation or mitochondria. Surprisingly, muscular and hepatic inflammation, SOCS3 upregulation and (proteolytic) increases in free amino acids and glutathione were already detectable in mice with precancerous PanINs. Studies of initial local triggers and defense mechanisms regarding cachexia are warranted for targeted anti-inflammatory prevention. MDPI 2022-05-11 /pmc/articles/PMC9139525/ /pubmed/35626644 http://dx.doi.org/10.3390/cells11101607 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Hildebrandt, Wulf
Keck, Jan
Schmich, Simon
Bonaterra, Gabriel A.
Wilhelm, Beate
Schwarzbach, Hans
Eva, Anna
Bertoune, Mirjam
Slater, Emily P.
Fendrich, Volker
Kinscherf, Ralf
Inflammation and Wasting of Skeletal Muscles in Kras-p53-Mutant Mice with Intraepithelial Neoplasia and Pancreatic Cancer—When Does Cachexia Start?
title Inflammation and Wasting of Skeletal Muscles in Kras-p53-Mutant Mice with Intraepithelial Neoplasia and Pancreatic Cancer—When Does Cachexia Start?
title_full Inflammation and Wasting of Skeletal Muscles in Kras-p53-Mutant Mice with Intraepithelial Neoplasia and Pancreatic Cancer—When Does Cachexia Start?
title_fullStr Inflammation and Wasting of Skeletal Muscles in Kras-p53-Mutant Mice with Intraepithelial Neoplasia and Pancreatic Cancer—When Does Cachexia Start?
title_full_unstemmed Inflammation and Wasting of Skeletal Muscles in Kras-p53-Mutant Mice with Intraepithelial Neoplasia and Pancreatic Cancer—When Does Cachexia Start?
title_short Inflammation and Wasting of Skeletal Muscles in Kras-p53-Mutant Mice with Intraepithelial Neoplasia and Pancreatic Cancer—When Does Cachexia Start?
title_sort inflammation and wasting of skeletal muscles in kras-p53-mutant mice with intraepithelial neoplasia and pancreatic cancer—when does cachexia start?
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139525/
https://www.ncbi.nlm.nih.gov/pubmed/35626644
http://dx.doi.org/10.3390/cells11101607
work_keys_str_mv AT hildebrandtwulf inflammationandwastingofskeletalmusclesinkrasp53mutantmicewithintraepithelialneoplasiaandpancreaticcancerwhendoescachexiastart
AT keckjan inflammationandwastingofskeletalmusclesinkrasp53mutantmicewithintraepithelialneoplasiaandpancreaticcancerwhendoescachexiastart
AT schmichsimon inflammationandwastingofskeletalmusclesinkrasp53mutantmicewithintraepithelialneoplasiaandpancreaticcancerwhendoescachexiastart
AT bonaterragabriela inflammationandwastingofskeletalmusclesinkrasp53mutantmicewithintraepithelialneoplasiaandpancreaticcancerwhendoescachexiastart
AT wilhelmbeate inflammationandwastingofskeletalmusclesinkrasp53mutantmicewithintraepithelialneoplasiaandpancreaticcancerwhendoescachexiastart
AT schwarzbachhans inflammationandwastingofskeletalmusclesinkrasp53mutantmicewithintraepithelialneoplasiaandpancreaticcancerwhendoescachexiastart
AT evaanna inflammationandwastingofskeletalmusclesinkrasp53mutantmicewithintraepithelialneoplasiaandpancreaticcancerwhendoescachexiastart
AT bertounemirjam inflammationandwastingofskeletalmusclesinkrasp53mutantmicewithintraepithelialneoplasiaandpancreaticcancerwhendoescachexiastart
AT slateremilyp inflammationandwastingofskeletalmusclesinkrasp53mutantmicewithintraepithelialneoplasiaandpancreaticcancerwhendoescachexiastart
AT fendrichvolker inflammationandwastingofskeletalmusclesinkrasp53mutantmicewithintraepithelialneoplasiaandpancreaticcancerwhendoescachexiastart
AT kinscherfralf inflammationandwastingofskeletalmusclesinkrasp53mutantmicewithintraepithelialneoplasiaandpancreaticcancerwhendoescachexiastart